In addition, a decrease in the number of amyloid plaques [41] as well as a decrease in neuronal loss [42] has been observed in CX3CR1-null mouse models of Alzheimer's disease. This evidence concerns the gene CX3CR1 and early-onset autosomal dominant Alzheimer disease.